Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New market introduction for antiestrogen

Nov. 28, 1996

New 5-FU formulation reduces toxicity in mice

Nov. 28, 1996

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Natural farnesyltransferase inhibitors from Kitasato Institute

Nov. 28, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

Protegrin development candidate selected by IntraBiotics

Nov. 26, 1996

Human brain-derived protein kinase offered for licensing

Nov. 26, 1996

Interim clinical results with Ansan's cancer product

Nov. 22, 1996

New target for drug-resistant tumors identified

Nov. 22, 1996

Mercian discloses novel mitomycin

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...